In patients with type 2 diabetes being treated with metformin, the addition of the glucagon-like peptide-1 analog liraglutide is as effective as glimepiride in improving glycemic control but with less weight gain, researchers report.

Targeting blood glucose concentrations to age-adjusted normal fasting concentrations was associated with better short-term outcome of patients in the pediatric intensive care unit (PICU), according to the results of a prospective, randomized controlled study.

Results of a new study indicate that a diabetes-management program is effective in a lower-income Latino population, but treatment compliance may be poor even with free medications.

A medical research team has verified genes that can be the cause of diabetes during pregnancy.

Despite frequent insulin use, glucose control is “suboptimal” among patients hospitalized in U.S. academic medical centers, according to a new study. Less then 10% of patients were seen by a endocrinologist or diabetologist.

Following gestational diabetes, treatment with metformin or intensive lifestyle interventions can prevent or delay diabetes from becoming permanent in the postpartum period, new research shows.

Results suggest that lowering of A1c levels can reduce the decline in cognitive function.

Rigorous workouts lasting as little as three minutes may help prevent diabetes by helping control blood sugar, British researchers said last week. Short bursts of intense exercise every few days over just 2 weeks could dramatically cut the risk of diabetes and heart disease.

Cell biology Professor Romeo Ricci and his team have discovered a new signal transduction pathway that might play an important role in the promotion of type 2 diabetes.

In the United States, nearly 13 percent of adults age 20 and older have diabetes but 40 percent of them have not been diagnosed, according to epidemiologists from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).